BioAgilytix Welcomes Dr. Dominique Gouty as Vice President of Business Operations

BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Dominique Gouty has joined the company as Vice President of Business Operations, where she will hold key roles in both technical and commercial biopharmaceutical services.  Bringing with her over 20 years of industry experience and a career spanning R&D, clinical operations, and manufacturing in several multi-national pharmaceutical organizations such as Eli Lilly and Johnson & Johnson, as well as smaller biotech companies and CROs,  Dr. Gouty is the leading expert in key subjects concerning preclinical and clinical bioanalysis for novel therapeutic biologics and biosimilars.  “The management team and I are very excited about the addition of Dominique to our team,” BioAgilytix Founder and Chief Scientific Officer, Dr. Afshin Safavi stated.  “Dominique brings with her an outstanding reputation that she has built as a prominent industry voice in the area of biologics, and is well-respected as an expert speaker and for publishing key articles and thought leadership pieces concerning effective routes to robust and rigorous immunoassays.  She has extensive experience ensuring strict GLP compliance for bioanalytical assays and has expert knowledge on the evolving standards of the FDA, EMA, and other regulatory agencies.  Dominique will help us increase our market leadership position while maintaining the high quality of scientific service that our customers have come to expect.”

Jim Datin, BioAgilytix Chief Executive Officer, commented that “we are thrilled to have Dominique join the BioAgilytix team to support the next phase of the Company’s growth.  BioAgilytix has emerged as the industry leader for large-molecule bioanalytical testing and has significantly expanded over the last several years.  With Dominique’s industry expertise and leadership, we are confident the Company will continue to grow organically as well as through strategic partnerships and acquisitions; allowing BioAgilytix to continue to meet and exceed the demands of pharmaceutical and biotechnology customers who entrust BioAgilytix with their most critical large-molecule drug programs.”

Dominique’s background adds even more depth to BioAgilytix’s senior scientific staff which averages 15+ years’ experience performing cell-based and immunoassay development and analysis.  “It is a pleasure working with such a talented group that understands the complexity of biologics,” said Dr. Gouty. “The level of skill and real-world insight that BioAgilytix offers is unmatched and I’m excited to be a part of a growing and energetic team.”

About BioAgilytix www.bioagilytix.com

BioAgilytix is a leading bioanalytical testing laboratory specializing in large-molecule bioanalysis.  Located in North Carolina’s Research Triangle, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assays services supporting the development and release testing of biologics and small molecule therapeutics. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP.

BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, sample and data integrity, and regulatory compliance through all phases of clinical development, acting as a trusted partner to 6 of the top 10 global pharmaceutical and biotech companies.

Share This